Dermata Therapeutics

(NASDAQ) DRMAW

Current Price$0.01

Market CapN/A

Since IPO (2021)-99%

5 YearN/A

1 Year-40%

1 Month-5%

Dermata Therapeutics Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$0.00

Net Income (TTM)

-$7.10M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

1.14 (Average)

Dividend

$0.00

Beta (Volatility)

1.14 (Average)

Price

$0.01

Volume

Open

$0.01

Price

$0.01

Volume

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.01 - $0.03

Estimated Earnings Date

Aug 18, 2026

Dividend

$0.00

Beta (Volatility)

1.14 (Average)

Price

$0.01

Volume

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.01 - $0.03

Estimated Earnings Date

Aug 18, 2026

DRMAW News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Dermata Therapeutics

Industry

Biotechnology

Sector

Health Care

Headquarters

San Diego, CA 92130, US

DRMAW Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

-1%

Return on Assets

-95%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

Volume

Avg. Volume

4.83K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$7.77M

EBITDA

-$7.77M

Operating Cash Flow

-$7.76B

Capital Expenditure

$0.00

Free Cash Flow

-$7.76B

Cash & ST Invst.

$7.52M

Total Debt

$0.00

Dermata Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

-$1.85M

+19.8%

EBITDA

-$1.93M

+17.7%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$6.95M

-28.5%

Accounts Receivable

$0.00

N/A

Inventory

$93.09K

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-95.14%

N/A

Return on Invested Capital

-1.15%

N/A

Free Cash Flow

-$2.48M

-28.2%

Operating Cash Flow

-$2.48M

-28.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

REVBRevelation Biosciences, Inc.

REVBRevelation Biosciences, Inc.$1.00+1.01%

VRPXVirpax Pharmaceuticals, Inc.

VRPXVirpax Pharmaceuticals, Inc.$0.00+0.00%

VINCVincerx Pharma, Inc.

VINCVincerx Pharma, Inc.$0.01+3.54%

PPBTPurple Biotech Ltd.

PPBTPurple Biotech Ltd.$2.86-3.70%

SLXNWSilexion Therapeutics Ltd.

SLXNWSilexion Therapeutics Ltd.$0.03-13.41%

SYRSSyros Pharmaceuticals, Inc.

SYRSSyros Pharmaceuticals, Inc.$0.00-50.00%

FOXOFOXO Technologies Inc.

FOXOFOXO Technologies Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INHDInno

INHDInno$6.64+5.32%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.63-0.06%

KEELKeel Infrastructure

KEELKeel Infrastructure$5.73+0.12%

LYGLloyds Banking Group Plc

LYGLloyds Banking Group Plc$5.30-0.00%

INTCIntel

INTCIntel$110.70+0.12%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$35.92+0.05%

NOKNokia

NOKNokia$14.75+0.03%

Questions About DRMAW

What is the current price of Dermata Therapeutics?

Dermata Therapeutics is trading at $0.01 per share.

What is the 52-week range for Dermata Therapeutics?

Over the past 52 weeks, Dermata Therapeutics has traded between $0.01 and $0.03.

How much debt does Dermata Therapeutics have?

Dermata Therapeutics total debt is unavailable.

How much cash does Dermata Therapeutics have on hand?

Dermata Therapeutics does not have cash on hand data available.

What is Dermata Therapeutics’s dividend yield?

Dermata Therapeutics does not currently have a dividend yield.

Dermata Therapeutics

Dermata Therapeutics Financials at a Glance

DRMAW News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Dermata Therapeutics

DRMAW Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Dermata Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About DRMAW

What is the current price of Dermata Therapeutics?

What is the 52-week range for Dermata Therapeutics?

How much debt does Dermata Therapeutics have?

How much cash does Dermata Therapeutics have on hand?

What is Dermata Therapeutics’s dividend yield?

Premium Investing Services